Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreasIrene Ischenko, Oleksi Petrenko, Michael J HaymanOncotarget|July 10, 2015
A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cellsIrene Ischenko, Oleksi Petrenko, Michael J HaymanMolecular and Cellular Biology|November 16, 2004
Ski negatively regulates erythroid differentiation through its interaction with GATA1Nobuhide Ueki, Leiqing Zhang, Michael J HaymanBiochemical and Biophysical Research Communications|August 10, 2010
The Ski protein negatively regulates Siah2-mediated HDAC3 degradationHong-Ling Zhao, Nobuhide Ueki, Michael J HaymanBiochimica Et Biophysica Acta|January 18, 2006
Mutation of Thr466 in SHP2 abolishes its phosphatase activity, but provides a new substrate-trapping mutantRebecca Merritt, Michael J Hayman, Yehenew M AgazieOncotarget|February 3, 2017
KRAS-dependent suppression of MYC enhances the sensitivity of cancer cells to cytotoxic agentsIrene Ischenko, Jizu Zhi, Michael J Hayman, et al.Oncogene|September 26, 2003
Scaffolding protein Gab2 mediates fibroblast transformation by the SEA tyrosine kinaseIrene Ischenko, Oleksi Petrenko, Haihua Gu, et al.Oncogene|October 10, 2003
The phosphotyrosine phosphatase SHP2 is a critical mediator of transformation induced by the oncogenic fibroblast growth factor receptor 3Yehenew M Agazie, Nieves Movilla, Irene Ischenko, et al.Nature Communications|November 7, 2013
Selective cancer targeting with prodrugs activated by histone deacetylases and a tumour-associated proteaseNobuhide Ueki, Siyeon Lee, Nicole S Sampson, et al.The Journal of General Physiology|June 16, 2005
An electrostatic engine model for autoinhibition and activation of the epidermal growth factor receptor (EGFR/ErbB) familyStuart McLaughlin, Steven O Smith, Michael J Hayman, et al.Pageof 4